[ U.S. CDMRP – Lung Cancer Research Program Career Development Award | Research Funding ]
Event details
| Date | 06.04.2021 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Lung Cancer Research Program (LCRP) Awards. The FY21 LCRP Career Development Award supports early-career, independent investigators to conduct impactful research under the mentorship of an experienced lung cancer researcher as an opportunity to obtain the funding, mentoring, and experience necessary for productive, independent careers at the forefront of lung cancer research. This award is intended to support impactful research projects with an emphasis on discovery. Preliminary data are not required.
In addition, all applications for LCRP funding must specifically address at least one of the Areas of Emphasis as directed by Congress and have direct relevance to military health. The FY21 LCRP Topic Areas are listed at the end of this announcement.
Funding: max. $250’000
Duration: 2 years
Eligibility: An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by or affiliated with an eligible organization. All organizations, including foreign organizations, foreign public entities, and international organizations, are eligible to apply. It is not required that the PI and the Mentor be located at the same institution.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 5:00 p.m. Eastern time (ET), April 6, 2021
Full Application Deadline: 11:59 p.m. ET, April 20, 2021 (invitation not required)
Grants.gov Funding Opportunity Number: W81XWH-21-LCRP-CDA
Further information
FY21 Areas of Emphasis
In addition, all applications for LCRP funding must specifically address at least one of the Areas of Emphasis as directed by Congress and have direct relevance to military health. The FY21 LCRP Topic Areas are listed at the end of this announcement.
Funding: max. $250’000
Duration: 2 years
Eligibility: An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by or affiliated with an eligible organization. All organizations, including foreign organizations, foreign public entities, and international organizations, are eligible to apply. It is not required that the PI and the Mentor be located at the same institution.
- The PI must be an independent investigator at the level of Assistant Professor, Instructor, or equivalent and be within 5 years of their first faculty appointment by the time of the application submission deadline
- The PI must not have received a Career Development Award (or equivalent) previously from any program within the CDMRP.
- The PI must not have received more than $300,000 in total direct costs for previous or concurrent lung cancer research as a PI of one or more federally or privately funded, non mentored, peer-reviewed grants.
- The PI’s institution must demonstrate a commitment to the PI through confirmation of laboratory space and at least 40% protected time for lung cancer research.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 5:00 p.m. Eastern time (ET), April 6, 2021
Full Application Deadline: 11:59 p.m. ET, April 20, 2021 (invitation not required)
Grants.gov Funding Opportunity Number: W81XWH-21-LCRP-CDA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-21-LCRP-CDA
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
FY21 Areas of Emphasis
- Identify innovative strategies for prevention of the occurrence of lung cancer
- Identify innovative strategies for the screening and early detection of lung cancer
- Understand the molecular mechanisms of initiation and progression to lung cancer
- Understand contributors to lung cancer development other than tobacco
- Identify innovative strategies for the treatment of lung cancer
- Identify innovative strategies for the prevention of recurrence of or metastases from lung cancer
- Develop or optimize prognostic or predictive markers to assist with therapeutic decision making
- Understand mechanisms of resistance to treatment (primary and secondary)
- Identify innovative strategies for lung cancer care delivery (clinical management/ surveillance/symptom management)
- Understand factors that contribute to the health disparities in lung cancer, such as biological contributors; environmental, social, and cultural factors; and access to health care
Practical information
- General public
- Free